Skip to main content

and
  1. No Access

    Article

    The role of anti-VEGF agents in the treatment of advanced gastric cancer: a meta-analysis of randomized controlled trials

    Inhibition of vascular epithelial growth factor (VEGF) signaling pathways has proven to be an effective strategy for the treatment of several common solid tumors, but its role in the management of advanced gas...

    Wei-**ang Qi, Zan Shen, Li-Na Tang, Yang Yao in Tumor Biology (2014)

  2. No Access

    Article

    Bevacizumab increases the risk of gastrointestinal perforation in cancer patients: a meta-analysis with a focus on different subgroups

    The aim of this meta-analysis was to gather current data and evaluate not only the risk of gastrointestinal (GI) perforation with bevacizumab, but also the potential risk factors for this adverse event.

    Wei-**ang Qi, Zan Shen, Li-Na Tang, Yang Yao in European Journal of Clinical Pharmacology (2014)

  3. No Access

    Article

    Treatment-related mortality with aflibercept in cancer patients: a meta-analysis

    Aflibercept, a fully humanized vascular endothelial growth factor (VEGF)-targeted agent, has emerged as an effective therapy in the treatment of various solid tumors. We carried out an up-to-date meta-analysis...

    Wei-**ang Qi, Li-Na Tang, Zan Shen, Yang Yao in European Journal of Clinical Pharmacology (2014)